These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 3513967)
21. Transcription regulation of peroxisomal fatty acyl-CoA oxidase and enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase in rat liver by peroxisome proliferators. Reddy JK; Goel SK; Nemali MR; Carrino JJ; Laffler TG; Reddy MK; Sperbeck SJ; Osumi T; Hashimoto T; Lalwani ND Proc Natl Acad Sci U S A; 1986 Mar; 83(6):1747-51. PubMed ID: 3456610 [TBL] [Abstract][Full Text] [Related]
22. Apoptosis of acinar cells in the pancreas of rats fed on a copper-depleted diet. Kishimoto S; Iwamoto S; Masutani S; Yamamoto R; Jo T; Saji F; Terada N; Sasaki Y; Imaoka S; Sugiyama T Exp Toxicol Pathol; 1994 Apr; 45(8):489-95. PubMed ID: 8054826 [TBL] [Abstract][Full Text] [Related]
23. Reduction of rat liver endoplasmic reticulum Ca(2+)-ATPase activity and mobilization of hepatic intracellular calcium by ciprofibrate, a peroxisome proliferator. Bennett AM; Williams GM Biochem Pharmacol; 1992 Feb; 43(3):595-605. PubMed ID: 1531754 [TBL] [Abstract][Full Text] [Related]
24. Dehydroepiandrosterone inhibits DNA synthesis of rat hepatocytes induced by partial hepatectomy or mitogen (ciprofibrate). Rao MS; Subbarao V Cell Prolif; 1997 Jan; 30(1):1-5. PubMed ID: 9332491 [TBL] [Abstract][Full Text] [Related]
25. Expression of liver peroxisomal proteins as compared to other organelle marker enzymes in rats treated with hypolipidemic agents. Cherkaoui Malki M; Bardot O; Lhuguenot JC; Latruffe N Biol Cell; 1990; 69(2):83-92. PubMed ID: 2271901 [TBL] [Abstract][Full Text] [Related]
26. Comparison of hepatic peroxisome proliferative effect and its implication for hepatocarcinogenicity of phthalate esters, di(2-ethylhexyl) phthalate, and di(2-ethylhexyl) adipate with a hypolipidemic drug. Reddy JK; Reddy MK; Usman MI; Lalwani ND; Rao MS Environ Health Perspect; 1986 Mar; 65():317-27. PubMed ID: 3709457 [TBL] [Abstract][Full Text] [Related]
27. Effect of ciprofibrate, bezafibrate, and LY171883 on peroxisomal beta-oxidation in cultured rat, dog, and rhesus monkey hepatocytes. Foxworthy PS; White SL; Hoover DM; Eacho PI Toxicol Appl Pharmacol; 1990 Jul; 104(3):386-94. PubMed ID: 1974728 [TBL] [Abstract][Full Text] [Related]
28. Pancreatic hepatocytes. An in vivo model for cell lineage in pancreas of adult rat. Reddy JK; Rao MS; Yeldandi AV; Tan XD; Dwivedi RS Dig Dis Sci; 1991 Apr; 36(4):502-9. PubMed ID: 2007367 [TBL] [Abstract][Full Text] [Related]
29. Liver-specific catalase expression in transgenic mice inhibits NF-kappaB activation and DNA synthesis induced by the peroxisome proliferator ciprofibrate. Nilakantan V; Spear BT; Glauert HP Carcinogenesis; 1998 Apr; 19(4):631-7. PubMed ID: 9600348 [TBL] [Abstract][Full Text] [Related]
30. Induction of peroxisome proliferation in rainbow trout exposed to ciprofibrate. Yang JH; Kostecki PT; Calabrese EJ; Baldwin LA Toxicol Appl Pharmacol; 1990 Jul; 104(3):476-82. PubMed ID: 2385837 [TBL] [Abstract][Full Text] [Related]
31. Treatment of rats with the peroxisome proliferator ciprofibrate results in increased liver NF-kappaB activity. Li Y; Leung LK; Glauert HP; Spear BT Carcinogenesis; 1996 Nov; 17(11):2305-9. PubMed ID: 8968042 [TBL] [Abstract][Full Text] [Related]
32. Conditions influencing the induction of peroxisomal beta-oxidation in cultured rat hepatocytes. Foxworthy PS; Eacho PI Toxicol Lett; 1986 Feb; 30(2):189-96. PubMed ID: 3458334 [TBL] [Abstract][Full Text] [Related]
33. Comparison of constitutive and inducible levels of expression of peroxisomal beta-oxidation and catalase genes in liver and extrahepatic tissues of rat. Nemali MR; Usuda N; Reddy MK; Oyasu K; Hashimoto T; Osumi T; Rao MS; Reddy JK Cancer Res; 1988 Sep; 48(18):5316-24. PubMed ID: 2900680 [TBL] [Abstract][Full Text] [Related]
34. Peroxisomal enzyme activities in brain and liver of pups of lactating mothers treated with ciprofibrate. Singh I; Lazo O Neurosci Lett; 1992 Apr; 138(2):283-6. PubMed ID: 1608540 [TBL] [Abstract][Full Text] [Related]
35. Lack of initiating activity of the peroxisome proliferator ciprofibrate in two-stage hepatocarcinogenesis. Glauert HP; Clark TD Cancer Lett; 1989 Feb; 44(2):95-100. PubMed ID: 2920376 [TBL] [Abstract][Full Text] [Related]
36. 32P-postlabeling analysis of peroxisome proliferator-DNA adduct formation in rat liver in vivo and hepatocytes in vitro. Gupta RC; Goel SK; Earley K; Singh B; Reddy JK Carcinogenesis; 1985 Jun; 6(6):933-6. PubMed ID: 4006083 [TBL] [Abstract][Full Text] [Related]